Erasca, Inc.
ERAS
$1.26
$0.0554.56%
| Weiss Ratings | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.19 | |||
| Price History | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -15.44% | |||
| 30-Day Total Return | -16.56% | |||
| 60-Day Total Return | -54.01% | |||
| 90-Day Total Return | -54.84% | |||
| Year to Date Total Return | -53.33% | |||
| 1-Year Total Return | -41.40% | |||
| 2-Year Total Return | -60.00% | |||
| 3-Year Total Return | -85.43% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -65.07% | |||
| 52-Week Low % Change | 0.42% | |||
| Price | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.45 | |||
| 52-Week Low Price | $1.20 | |||
| 52-Week Low Price (Date) | Apr 01, 2025 | |||
| 52-Week High Price (Date) | Jul 26, 2024 | |||
| Valuation | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 341.34M | |||
| Enterprise Value | -47.25M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.75 | |||
| Earnings Per Share Growth | -10.36% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.81 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.26 | |||
| Enterprise Value/EBITDA (TTM) | 0.32 | |||
| Enterprise Value/EBIT | 0.31 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 282.85M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 858 465 6511 | |||
| Address | 3115 Merryfield Row San Diego, CA 92121 | |||
| Website | www.erasca.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -21.22% | |||
| Return on Equity | -- | |||
| Income Statement | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -148.58M | |||
| EBIT (TTM) | -152.39M | |||
| Net Income (TTM) | -161.65M | |||
| Net Income Avl. to Common (TTM) | -161.65M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -8.52% | |||
| EPS Diluted (TTM) | -0.75 | |||
| EPS Diluted Growth (Q YOY) | 42.13% | |||
| Balance Sheet | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 298.31M | |||
| Cash Per Share (Q) | $1.05 | |||
| Total Current Assets (Q) | 308.79M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 423.50M | |||
| Current Ratio (Q) | 9.836 | |||
| Book Value Per Share (Q) | $1.50 | |||
| Total Assets (Q) | 502.53M | |||
| Total Current Liabilities (Q) | 31.40M | |||
| Total Debt (Q) | 51.89M | |||
| Total Liabilities (Q) | 79.03M | |||
| Total Common Equity (Q) | 423.50M | |||
| Cash Flow | ERAS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -156.62M | |||
| Cash from Financing (TTM) | 240.70M | |||
| Net Change in Cash (TTM) | -25.34M | |||
| Levered Free Cash Flow (TTM) | -84.59M | |||
| Cash from Operations (TTM) | -109.42M | |||
